A Win For Ignyta, Inc.
Fri, Mar 12, 2021 at 05:33 PM
Ignyta, Inc. (RXDX:NASDAQ) jumped higher at $25.29, representing a gain of 33.1%. The stock got featured on our News Catalysts scanner on Fri 12 Mar 21 at 01:50 PM in the 'PUBLIC OFFERING' category.
About Ignyta, Inc. (RXDX:NASDAQ)
Ignyta Inc is a precision oncology biotechnology company. Its research is targeting tumor reduction and cancer treatment through both integrated therapeutic and companion diagnostics. It aims to develop and commercialize molecularly targeted therapies.
Top 10 Gainers:
- NLSP (NLSP:NASDAQ), 106.71%
- Entera Bio Ltd. (ENTX:NASDAQ), 70.79%
- Seelos Therapeutics, Inc. (SEEL:NASDAQ), 56.25%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 35.71%
- EBON (EBON:NASDAQ), 35.24%
- Ignyta, Inc. (RXDX:NASDAQ), 33.11%
- Synthetic Biologics, Inc. (SYN:NYSEMKT), 29.72%
- Aemetis, Inc. (AMTX:NASDAQ), 25.33%
- PlayAGS, Inc. (AGS:NYSE), 23.3%
- CLPS Incorporation (CLPS:NASDAQ), 23.2%